Real Zylar check

An AI scribe for vet clinics: a real Zylar check (Rethink, 36)

Last updated: November 20, 2026

4 min read8 sections

The short answer

Zylar gave this idea a Rethink, 36 out of 100. Vets already pay for scribes, so the need is real. The problem is the shelf: about 20 vendors already sell scribes made for vets, most for $99 to $150, and the two most used now belong to practice software companies. At $199 per vet a month, the idea has no visible reason to win. A Rethink is not a dead end: the report pointed to a cheaper, software-neutral version to test.

36/100
Rethink: hard to make work as described
17
sources the agents read for this check
~20
vet scribes already on sale

Hypothetical idea, real Zylar check, run on November 8, 2026. The scores, findings and suggestions below come from the report, shortened but not changed. No real company is behind this idea.

The idea as it was typed in

  • The idea: an AI scribe that writes visit notes for independent veterinary clinics, sold as a monthly subscription.
  • Where it starts: independent small-animal clinics in Ohio.
  • First customers: owner vets at clinics with one to four doctors.
  • Price: $199 per vet a month, with a two-week free trial.
  • How they'd reach them: Ohio Veterinary Medical Association events and vet Facebook groups.
  • Why they'd switch: notes in the standard vet format, with species and dosing built in.

What each agent found

AgentScoreWhat it found
Market38Vets already pay for scribes. Ohio has about 1,250 clinics, and the state association has more than 2,800 members. But $199 sits at the top of a $0 to $200 range where most tools cost $99 to $150.
Competitor22About 20 vendors already sell vet-specific scribes. The two most used now belong to practice software companies, and flat per-clinic plans start at $119. The only visible opening is a scribe that works with any practice software.
Feasibility52One person can build voice-to-notes, and a copy-paste first version is workable. Writing notes back into practice software and getting dosing right are hard for a solo builder.
Risk30No federal approval needed, and HIPAA does not apply to animal records. Commercial risk is high. Wrong doses invented by the AI create liability, and some states have recording consent rules.

The verdict

Rethink, 36 out of 100. Strongest area: feasibility. Main gap: competition, with no evidence yet that Ohio vets would pay $199 over $50 to $99 rivals. Evidence so far: Building.

A Rethink means the idea is hard to make work as described. It's cheaper to hear that before you spend the year.

What to prove next

  1. Paying clinics. Three Ohio clinics move from a free trial to paying $150 or more per vet a month.
  2. Notes without integration. Five pilot clinics accept copy-paste notes, without write-back into their software, after two weeks.
  3. Better than the cheap option. In a blind review of 10 identical recordings, the notes beat a $50-tier rival.

Changes the report suggested

The report projected how much each change could move the score. These are estimates to test, not promises.

  • Flat per-clinic pricing in the $50 to $150 band. About +8%.
  • Work with any practice software, as the clear position against scribes owned by software vendors. About +7%.
  • Dosing limited to citations from licensed references. About +4%.
  • A paid-conversion pilot with 5 to 10 clinics. About +4%.

Find the opening: five nearby ideas

Find the opening looked for room in a market that is consolidating. Its five openings are hypotheses to test, most with the result that would rule them out.

OpeningDistanceWhat would rule it out
A scribe that works with any practice software, for small independent clinicsNearClinics prefer the scribe bundled with their software, or need write-back
Flat per-clinic pricing for one to four doctor practicesNearThe cost per visit leaves too little margin
Recording consent and compliance tools for clinicsAdjacentNot given; the report rated the evidence early
A dosing safety check that cites licensed referencesAdjacentNot given; the report rated the evidence early
A copy-paste first version with a paid pilot through the Ohio association, priced at $50 to $150NearNot given in the report

What this check can't tell you

Whether vets will switch. Only paying clinics prove that, which is why the verdict ends with a paid pilot. Zylar's verdicts are advisory and are not professional, legal or financial advice. You decide.

Questions

Is this a real company? No. It's a hypothetical idea we typed into Zylar to show what a check returns. The scores, findings and sources are real.

What did the agents read? 17 sources, including the American Veterinary Medical Association's 2025 economic report, VIN News, Frontiers in Veterinary Science and vendors' own pricing pages.

Why publish a low score? Because a check that only says yes is no use. Of the ideas on our examples page, the EV charger service came back Rework, 48 and a pharmacy hearing kit came back Rethink, 31.

Zylar is free during the alpha, and your ideas stay private: they are never used to train AI models. Join the waitlist and we'll let you in with the next batch.